logo
English (United Kingdom)Ukrainian (UA)
RESEARCH Protein Kinase Inhibitors FGFR1 Inhibitors N-phenylnaphthostyril-1-sulfonamides

N-phenylnaphthostyril-1-sulfonamides

New class of FGFR1 kinase inhibitors with naphthostyril heterocycle has been identified. A series of N-phenylnaphthostyril-1-sulfonamides has been synthesized and tested in vitro. It was revealed that the most active compound N-(4-hydroxyphenyl)naphthostyril-1- sulfonamide inhibited FGFR1 with IC50 of 2 μM. In our preliminary studies, N-phenylnaphthostyril-1-sulfonamides demonstrated selectivity of FGFR1 inhibition and antiproliferative activity on cancer cell line. N-phenylnaphthostyril-1-sulfonamides have a good potential for further development as anticancer agents.

fgfr1_im4_new1
Figure 1. N-phenylnaphthostyril-1-sulfonamide inhibitor of FGFR1.


  • A.A. Gryshchenko, K.V. Levchenko, V.G. Bdzhola, T.P. Ruban, L.L. Lukash, S.M. Yarmoluk. (2015) Design, synthesis and biological evaluation of naphthostyril derivatives as novel protein kinase FGFR1 inhibitors. J Enzyme Inhib Med Chem 30(1):126-132.

Other kinase inhibitors research:

ASK1 Inhibitors
Identification of 3H-naphtho[1,2,3-de]quinoline-2,7-diones as Inhibitors of ASK1 Image
Virtual screening and biochemical screening allowed us to identify...



 

CK2 Inhibitors
2-aminopyrimidinones and their 6-aza-analogs Image
In order to find the new potent CK2 inhibitors 60 derivatives of...



 

FGFR1 Inhibitors
Flavones Image
One of the first discovered in the screening of inhibitors of FGFR1 classes are...



 

© 2012 All rights reserved
footer logo